SIC
BNTX icon

Salem Investment Counselors’s BioNTech BNTX Stock Holding History

Salem Investment Counselors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20
Closed -$3K – 1123
2022
Q4 		$3K Buy
+20
New +$3.08K ﹤0.01% 921
2021
Q2 		– Sell
-14
Closed -$2K – 908
2021
Q1 		$2K Buy
+14
New +$1.49K ﹤0.01% 794

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Salem Investment Counselors's BNTX Position: Q1 2023 in Review

Salem Investment Counselors sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 20 shares — an estimated $3K sold.

Salem Investment Counselors first reported a position in BNTX in Q1 2021 and held it in 2 quarters. The position peaked at $3K in Q4 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

  • Salem Investment Counselors reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
  • Salem Investment Counselors sold 20 BioNTech shares in Q1 2023, an estimated $3K.
  • Salem Investment Counselors first reported a position in BioNTech in Q1 2021 and held it in 2 quarters.
  • Salem Investment Counselors's BioNTech position peaked at $3K in Q4 2022.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Salem Investment Counselors's 13F filing for Q1 2023, filed 11 May 2023.